StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and a $3.00 price […]

Related Keywords

Dawson James , Zembrace Symtouch , Institutional Investors Weigh In On Tonix Pharmaceuticals , Tonix Pharmaceuticals Holding Corp , Tonix Pharmaceuticals Price Performance , Tonix Pharmaceuticals , Armistice Capital , Acadian Asset Management , News Ratings For Tonix Pharmaceuticals Daily , Sabby Management , Free Report , Get Free Report , Asset Management , Pharmaceuticals Holding Corp , Tonix Pharmaceuticals Daily ,